Zepp Health (ZEPP) Stock Price

Zepp Health Price

NYSE·CLOSED
4.14
+0.02 (+0.48 %)
Market closed

Revenue has compounded at 7.0% per year over the past 10 years to 1.82 B USD. Earnings per share have grown at 4.1% per year over the last 5 years. Zepp Health's net margin stands at -15.5%, down from 2.2% several years earlier. Analysts set a median price target of 12.00 USD, implying 189.9% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 4% above its 52-week low.

Zepp Health stock price

Access this data via the Eulerpool API

Zepp Health business model & stock analysis

Frequently asked questions about Zepp Health

Analysts currently set an average price target of 12.00 USD for the Zepp Health stock (median: 12.00 USD), implying +189.9 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Zepp Health stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Zepp Health share trades at 3.63 EUR (4.14 USD).

No history available for Zepp Health.

The expected revenue of Zepp Health is 2.26 B USD. This figure is based on current financial data and reflects the company's business performance.

The profit cannot currently be calculated for Zepp Health.

The P/E ratio cannot be calculated for Zepp Health at the moment.

The price-to-sales ratio (P/S) of Zepp Health is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Zepp Health stock.

The Eulerpool Quality Score for Zepp Health is 2/10.

The ISIN of Zepp Health is US98945L2043. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Zepp Health is ZEPP. The ticker symbol is used to trade Zepp Health shares on the stock exchange.

Zepp Health paid dividends every year for the past 0 years.

Zepp Health is assigned to the 'Information technology' sector.

The dividends of Zepp Health are distributed in USD.

Fair ValueTerminal
4.02 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Electronic Equipment, Instruments & Components
Number of shares
Employees
Revenue per Employee
2.82 M USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website zepp.com
Currency
USD
Initial public offering
Feb 8, 2018
ISIN
US98945L2043
Cusip
44331K103
Market capitalization
35.02 M USDMicro Cap
52-Week Range
3.99–61.27USD
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2026
—
P/Ee 2027
—
P/S
P/Se
0.00
EV/EBIT
—
P/B Ratio
0.02
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-10.29 %
Gross Margin
39.20 %
EBIT Margin
-14.27 %
Net Margin
-15.48 %
EPS (Earnings Per Share)
-283.10 USD
Net Debt / EBIT
-1.70
Debt/Equity
0.82
Last updated Sep 27, 2026, 9:17 AM

Zepp Health Peer Group

All fundamentals and in-depth analysis of Zepp Health

Our stock analysis for Zepp Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zepp Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.